United States · Funded startup

Who invested in Genomatica

5 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$203Mraised across 5 rounds since 2010, from 5 sources

$15MSeries C$45MVenture$46MVenture$6.8MDebt$90MRound
Latest round
Round, $90MOct 2018
Step-upi
13.3×
Investors
7
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20102012201420162018
$15MSeries C$45MVenture$46MVenture$6.8MDebt$90MRound
First round
Series C, $15M
Apr 2010
Biggest round
$90M
Round · Oct 2018
Usual gap between rounds
19 months
the median of 4

The rounds

  1. Oct 2018
    Round$90M2 new

    Reported by Synbiobeta

  2. Mar 2014
    Debt$6.8M

    No investor was named in the report.

    From a historical funding recordSEC filing: $6.8M sold, first sale Feb 2014

  3. Aug 2012
    Venture$46M

    No investor was named in the report.

    Reported by sec.govSEC filing: $46M sold, first sale Jul 2012

  4. Mar 2011
    Venture$45M1 new

    Reported by gigaom.com

  5. Apr 2010

Founders and team

From Genomatica's own website and the SEC filings it signed: 3 founders, 8 on the team.

Max KufnerCo-founder & CEO
Dr. Torbjørn Ølshøj JensenCo-founder & CSO
Prof. Alex NielsenCo-founder
  • Benedikt ManigoldChief Financial Officer
  • Dr. Konrad MillerChief Technology Officer
  • Dr. David BauwensVP of R&D
  • Carlos A. CabreraExecutive Officer, Directori
  • Christophe SchillingExecutive Officer, Directori
  • David Bendsen MuldoonExecutive Officeri
  • Rasmus Bendsen von GottbergExecutive Officeri
  • Thomas Bendsen McDonaldExecutive Officeri

On the board, as filediAnders Bendsen SpohrCraig A. BinettiEli A. CasdinJason A. Kelly

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series C2010Venture2011Venture2012Debt2014Round2018DFJMohr Davidow VenturesAlloy VenturesBright CapitalTPG Biotechnology PartnersGinkgo BioworksCasdin Capital/ Viking Global Investors

Everyone who backed them

DFJVC firm1round
Alloy VenturesVC firm1round
Bright CapitalInvestment firm1round
TPG Biotechnology PartnersGrowth equity1round
Ginkgo BioworksCorporate VC1round
Casdin Capital/ Viking Global Investorsno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Genomatica as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

VantagePoint Capital PartnersVC firmPer its own site
Thule InvestmentsInvestment firmPer its own site
Brú Venture CapitalVC firmPer its own site

Quick answers about Genomatica

Who invested in Genomatica?

Genomatica's investors include DFJ, Mohr Davidow Ventures, Alloy Ventures, Bright Capital and TPG Biotechnology Partners, and 2 more on record.

How much has Genomatica raised?

Genomatica has raised $203M across 5 rounds since 2010.

When did Genomatica last raise?

Genomatica's most recent round was an Undisclosed round of $90M in Oct 2018.

What was Genomatica's biggest round?

Its most recent round, $90M in Oct 2018, is also its largest on record.

Who backed Genomatica first?

Genomatica's first round on record, in Apr 2010, was backed by DFJ, Mohr Davidow Ventures and Alloy Ventures and 1 others.

What stage is Genomatica at?

Genomatica's latest named round is an Undisclosed round, in Oct 2018.

Where is Genomatica based?

Genomatica is based in the United States.

Companies like Genomatica

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.